Phocas Financial Corp. Laboratory Corp Of America Holdings Transaction History

Phocas Financial Corp.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 13, 2023	BUY	$213.32 - $257.83 $213 - $257	1 Added 0.07%	1,409 $323,000
Q4 2022 Jan 10, 2023	SELL	$203.72 - $248.97 $134,251 - $164,071	-659 Reduced 31.88%	1,408 $0
Q3 2022 Oct 14, 2022	BUY	$204.81 - $262.19 $47,311 - $60,565	231 Added 12.58%	2,067 $423,000
Q2 2022 Aug 15, 2022	BUY	$213.86 - $277.87 $213 - $277	1 Added 0.05%	1,836 $430,000
Q3 2017 Nov 17, 2017	BUY	$149.47 - $160.56 $274,277 - $294,627	1,835	1,835 $0

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $21.6B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Phocas Financial Corp., based on Form 13F filings with the SEC.

Stay updated on Phocas Financial Corp. with notifications on news.